Congress Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$26.2M Buy
141,370
+34,488
+32% +$6.41M 0.25% 94
2025
Q1
$22.4M Buy
106,882
+9,338
+10% +$1.82M 0.27% 95
2024
Q4
$17.3M Sell
97,544
-93,697
-49% -$17.2M 0.24% 122
2024
Q3
$37.8M Buy
191,241
+24,260
+15% +$4.53M 0.5% 44
2024
Q2
$28.6M Buy
166,981
+52,161
+45% +$8.64M 0.46% 47
2024
Q1
$20.9M Sell
114,820
-10,187
-8% -$1.76M 0.36% 66
2023
Q4
$19.4M Buy
125,007
+21,464
+21% +$3.13M 0.36% 64
2023
Q3
$15.4M Buy
103,543
+4,199
+4% +$616K 0.32% 71
2023
Q2
$13.4M Buy
99,344
+1,242
+1% +$182K 0.31% 86
2023
Q1
$15.6M Buy
98,102
+1,217
+1% +$186K 0.38% 59
2022
Q4
$15.7M Buy
96,885
+2,348
+2% +$360K 0.4% 52
2022
Q3
$12.7M Buy
94,537
+2,259
+2% +$324K 0.34% 70
2022
Q2
$14.1M Sell
92,278
-2,186
-2% -$334K 0.36% 62
2022
Q1
$15.3M Sell
94,464
-1,717
-2% -$249K 0.33% 68
2021
Q4
$13M Buy
+96,181
New +$11.4M 0.26% 105

Other funds holding ABBV